EX-FILING FEES 10 bivi_s1ex107.htm CALCULATION OF FILING FEE TABLES

Exhibit 107

 

Calculation of Filing Fee Tables

 

FORM S-1

(Form Type)

 

BIOVIE INC.

(Exact Name of Registrant as Specified in its Charter)

 

Table 1: Newly Registered Securities

 

  Security
Type		 Security Class Title Fee
Calculation
Rule		 Amount
Registered		 Proposed
Maximum
Offering
Price Per
Share

Maximum
Aggregate
Offering

Price(1)(2)

 Fee Rate Amount of
Registration
Fee
Fees to Be Paid Equity Units consisting of (3) 457(o) - - $17,250,000 $0.0001531 $2,640.98
Fees to Be Paid Equity (i) one share of Class A Common Stock (4) - - - - - -

Fees to Be Paid

 

 Equity (ii) one Warrant to purchase one share of Class A Common Stock (4) - - - - - -
Fees to Be Paid Equity Pre-Funded Units consisting of (3) - - - - - -
Fees to Be Paid Equity (i) one Pre-Funded Warrant to purchase one share of Class A Common Stock (4) - - - - - -
Fees to Be Paid Equity (ii) one Warrant to purchase one share of Class A Common Stock (4) - - - - - -
Fees to Be Paid Equity Shares of Class A Common Stock Underlying Warrants (3) 457(o) - - $21,562,500 (5) $0.0001531 $3,301.22
Fees to Be Paid Equity Shares of Class A Common Stock underlying Pre-Funded Warrants (3) - - - - - (3)
  Total Offering Amounts - - - - $38,812,500 $0.0001531 $5,942.20
  Total Fee Offsets             $5,942.20
  Net Fee Due - - - - - - $0

 

(1) This registration statement also includes an indeterminate number of securities that may become offered, issuable or sold to prevent dilution resulting from stock splits, stock dividends and similar transactions, which are included pursuant to Rule 416 under the Securities Act of 1933, as amended (the “Securities Act”).
   
(2) Includes the offering price of additional shares of Class A Common Stock, Pre-funded Warrants or Warrants or any combination thereof that the underwriters have the option to purchase to solely cover over-allotments, if any.
   
(3) The proposed maximum aggregate offering price of the Units will be reduced on a dollar-for-dollar basis based on the offering price of any Pre-Funded Units issued in the offering, and the proposed maximum aggregate offering price of the Pre-Funded Units to be issued in the offering will be reduced on a dollar-for-dollar basis based on the offering price of any Units issued in the offering. Accordingly, the proposed maximum aggregate offering price of the Units and Pre-Funded Units (including the common stock issuable upon exercise of the Warrants and the Pre-Funded Warrants), if any, is $17,250,000.
   
(4) No separate registration fee is payable pursuant to Rule 457(g) under the Securities Act.
   
(5) As estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(g) under the Securities Act, the proposed maximum aggregate offering price of the shares underlying the Warrants is equal to $21,562,500 (which is equal to 125% of the proposed maximum aggregate offering price for the Units of $17,250,000).

 

   

 

 

Table 2: Fee Offset Claims and Sources

 

    Registrant
or Filer Name		   Form or
Filing Type		   File Number     Initial
Filing Date		   Filing
Date		   Fee Offset
Claimed		     Security
Type
Associated
with Fee
Offset
Claimed		   Security
Title
Associated
with Fee
Offset
Claimed		   Unsold
Securities
Associated
with Fee
Offset
Claimed		     Aggregate
Offering
Amount
Associated
with Fee
Offset
Claimed		     Fee Paid
with Fee
Offset
Source		  
Rules 457(b) and 0-11(a)(2)  
Fee Offset Claims   BioVie Inc.   Schedule 14C   001-39015     05/14/2021         5,942.20(1)                                
Fee Offset Sources   BioVie Inc.   Schedule 14C   001-39015         05/14/2021                                   5,942.20(1)  

 

(1) The registrant previously filed a Preliminary Information Statement on Schedule 14C (File No. 001-39015) with the U.S. Securities and Exchange Commission (the “SEC”) on May 4, 2021 (the “Schedule 14 C”). A filing fee of $344,090 was paid in connection to the filing of the Schedule 14 C pursuant to Rule 14(g) of the Securities Exchange Act of 1934, as amended. Such filing fee for the Schedule 14 C was reduced to $40,297 upon the filing of the Amendment No. 1 to the Schedule 14 C on May 10, 2021, leaving $303,792 in previously paid fees available for future offset (the “unused filings fees”). In accordance with Rule 457(b) under the Securities Act, the Company used (i) $5,078.26 to offset the filing fee payable in connection with the registration statement on Form S-8 (File No. 333-260019), filed with the SEC on October 4, 2021; (ii) $3,801.90 of the unused filing fees to offset the filing fee payable in connection with the registration statement on Form S-1 (File No. 333-268313), filed with the SEC on November 10, 2022; (iii) $74.10 of the unused filing fees to offset the filing fee payable in connection with the registration statement on Form S-1 (File No. 333-271054), filed with the SEC on March 31, 2023; (iv) $33,189.50 of the unused filing fees to offset the filing fee payable in connection with the registration statement on Form S-3 (File No. 333-274083), filed with the SEC on August 18, 2023; and (v) $3,730.85 of the unused filing fees to offset the filing fee payable in connection with the registration statement on Form S-1 (File No. 333-283394), filed with the SEC on November 21, 2024. In accordance with Rule 457(b) under the Securities Act, the registrant is using $5,942.20 of the unused filing fees to offset the filing fee payable in connection with this registration statement, no registration fee is due to be paid at this time.